
Single-dose vaccines delivered via a new technology platform may offer full protection against Zika, Lassa fever, and Ebola.
Single-dose vaccines delivered via a new technology platform may offer full protection against Zika, Lassa fever, and Ebola.
Researchers find that Treg cells could be vital in protecting infants in the womb from mother-to-child HIV transmission.
The CDC has announced an investigation of a multistate outbreak of Salmonella Adelaide infections that have been linked with pre-cut melon.
The pharmaceutical giant will also launch a program committed to equitable pricing in malaria-endemic countries for new treatments along with expanding pediatric treatment availability and work to strengthen health care systems in 4 African nations.
The name change represents a new chapter for the organization after 50 years of service, in addressing the scope of health care challenges in the region today.
Results from a Johns Hopkins study conducted at Frere Hospital in South Africa indicate that emergency departments play a critical role in promoting HIV testing.
The first reports of H7N9 infection amongst humans occurred in China in 2013.
The Antibacterial Resistance Leadership Group (ARLG) is working to enroll patients in clinical trials of 2 investigational monoclonal antibodies, with the ultimate goal of reducing antimicrobial resistance.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.
The results of the trial revealed that the tablet reduced the rate of infection with influenza by 48%.
The investigators concluded that 2 separate immune pathways are key players in the way in which the body deals with chlamydia: one pathway clears the bacteria, while another fuels inflammation and tissue damage.
Providing investments in 10 vaccines during a 15-year period in low- and middle-income nations could prevent 36 million deaths and 24 million cases of poverty related to medical reasons.
A new systematic review of published research suggests that methotrexate could potentially be the best co-treatment option for chronic arthritis associated with the chikungunya virus.
A second hospital finds that the combination of a mechanical initial specimen diversion device (ISDD) and staff education resulted in about a decrease in the contamination of blood cultures.
The vaccine candidate is ASP0113, which was in development to treat and prevent cytomegalovirus (CMV) in hematopoietic stem cell transplant recipients.
The Cystic Fibrosis Foundation has awarded Motif Bio with $120,000 that will fund in vitro testing for the development of iclaprim to benefit patients with cystic fibrosis who have lung infections.
Vela Diagnostics has reached an agreement with the University of California, San Francisco for licensing 2 technologies.
Aetna has agreed to a $17 million settlement of a lawsuit centering around the HIV privacy violation that affected approximately 12,000 of the insurer’s customers in 2017.
The eNose was also able to recognize methicillin-resistant Staphylococcus aureus (MRSA) from methicillin-sensitive Staphylococcus aureus (MSSA).
A new data analysis suggests that individuals born at the time of a flu pandemic are more susceptible to death in future pandemics.
A new study suggests that Salmonella may have played a significant role in an epidemic that killed over 7 million Aztecs during the 16th century.
A new study indicates that casual contact, such as kissing, is not a major threat in the transmission of Zika virus.
The results of a new study reveal increased risk of cardiovascular disease in adults previously hospitalized for pneumonia or sepsis.
A recent study suggests that Ebola virus RNA can remain in the genital tract for more than 2 years following the acute infection period.
An ingestible smart pill developed by Proteus Digital Health can remind patients with chronic diseases to take their medication.
A new study reports that Escherichia coli (E. coli) bacteria are commandeering copper ions to strengthen bacteria levels in hard-to-treat urinary tract infections (UTIs).
Researchers from the University of Florida recently made an interesting discovery about the mosquitoes in the state.
Data gleaned from a new study suggests that drug-resistant “superbugs” are not necessarily out-competing other strains.
The NIH has released the findings of the first of 2 early-stage clinical trials on assessing the safety and effectiveness of HIV candidate vaccinations that support additional development of vaccines.
Scientists make an interesting connection between bats and detecting undiscovered disease.